-
Mashup Score: 0Intravascular Imaging-Guided or Angiography-Guided Complex PCI: Is it Time For a Change in Practice? - American College of Cardiology - 2 year(s) ago
Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) has been associated with improved clinical outcomes compared with angiography-guided PCI in randomized trials.1-3 Previous studies have also demonstrated the utility of optical coherence tomography (OCT) as an adjunct to PCI.4 As a result, the 2021 American College of Cardiology/American Heart Association/Society for…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial - 2 year(s) ago
Objective To investigate whether supplementing older adults with monthly doses of vitamin D alters the incidence of major cardiovascular events. Design Randomised, double blind, placebo controlled trial of monthly vitamin D (the D-Health Trial). Computer generated permuted block randomisation was used to allocate treatments. Setting Australia from 2014 to 2020. Participants 21 315 participants…
Source: The BMJCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/khGmufVNXN
-
-
Mashup Score: 0Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice - 2 year(s) ago
Medical therapy for heart failure (HF) has made substantial progress during recent years, and the ‘fantastic four’ drugs angiotensin receptor–neprilysin inhibit
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN @MihaiTrofenciuc #CardioTwitter https://t.co/BzJUf2OxXx
-
-
Mashup Score: 0Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation - 2 year(s) ago
AbstractBACKGROUND. In patients undergoing catheter ablation for atrial fibrillation (AF), direct oral anticoagulants (DOAC) are as effective and safe as the vi
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/GSOJcpVPIF
-
-
Mashup Score: 0Personalised antiplatelet therapies for coronary artery disease: what the future holds - 2 year(s) ago
Abstract. Coronary artery disease (CAD) is one of the leading causes of death globally, and antiplatelet therapy is crucial for both its prevention and treatmen
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/uYUmWB0AdC
-
-
Mashup Score: 0Evidence Generation for Novel Cardiovascular Devices - 2 year(s) ago
Over the last 50 years, cardiovascular medicine has had a substantial effect on human health through careful and continuous innovation and the application of therapies that have been evaluated in randomized clinical trials,1 including numerous advances in the care of patients with acute myocardial…
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/FuxqBd12MN
-
-
Mashup Score: 0Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction - 2 year(s) ago
Cardio-renal-metabolic (CRM) conditions are individually common among patients with heart failure (HF), but the prevalence and influence of overlappin…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/jlkp36LN7a
-
-
Mashup Score: 0U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease - Agepha Pharma US - 2 year(s) ago
LODOCO® (colchicine, 0.5 mg tablets) reduces cardiac event risk in adult patients with established Atherosclerotic Cardiovascular Disease (ASCVD) by an additional 31% on top of standard of care including high intensity statins.
Source: Agepha Pharma USCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN @MihaiTrofenciuc #CardioTwitter https://t.co/0i9LKCyNMP
-
-
Mashup Score: 0FDA Approves Colchicine for Decreasing CV Events - 2 year(s) ago
(UPDATED) In a big moment for the “inflammatory hypothesis,” the drug, to be sold as Lodoco, is the first anti-inflammatory for CVD.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN #CardioTwitter https://t.co/eKirv3Mlgk
-
-
Mashup Score: 0The Pause | Jonathan Bartels - 2 year(s) ago
Pausing after death as a means to offer closure to the medical team, family and offering honor to the patient
Source: The Pause | Jonathan BartelsCategories: Cardiologists, Latest HeadlinesTweet-
@CardioIAN @MihaiTrofenciuc #CardioTwitter https://t.co/4NgqaXHCMJ
-
@CardioIAN #CardioTwitter https://t.co/XZKpUmrTFz